The North America Wearable Injectors Market would witness market growth of 8.9% CAGR during the forecast period (2022-2028).
The device is intended to be prefilled with medicine and kept cold. The device container is approximately 76mm (3.0 inches) long in its current 3ml configuration. The needle enters the skin with the push of a button once the device is attached to the user's body. It should be spun 90 degrees anti-clockwise in the patient's hand. During the injection procedure, the device makes no noise. The needle retracts after completion, and the user can remove and dispose it. These devices significantly streamline the injection process, due to which, the demand for them is rapidly increasing among consumers.
Beyond the device's simplicity, wearable injectable devices provide a slew of advantages to users and medication companies. The device's capabilities enable it to give bigger dosages along with higher viscosities, and in some circumstances both. This is done while minimizing the patient's discomfort from higher doses and, in many situations, reducing the total number of injections required. These items can enable medication delivery in the patient's home rather than a clinical setting in cases where pharmaceuticals are supplied intravenously over extended periods of time, such as in the diagnosis of cancer or auto-immune illnesses. Keeping unnecessary time in the hospital or clinical setting to a minimum lowers the risk of hospital-acquired infections (HAIs).
Chronic diseases are long-term illnesses that develop gradually over time, typically worsening in severity, and can be regulated but not cured. Cardiovascular disorders (stroke and heart disease), cancer, arthritis, diabetes, back pain, asthma, and persistent depression are among them. Chronic diseases can drastically impair daily physical and mental processes, as well as limit one's capacity to undertake daily activities. Chronic diseases have surpassed infectious diseases as the primary cause of mortality and disability around the world. According to the Ministry of Health, noncommunicable illnesses currently account for 59% of the world's 57 million annual deaths and 46% of the global disease burden. The situation is very similar in Ontario. Heart disease was the biggest cause of death in the province in 2003, with myocardial infarction being the most common type of heart illness. Cancer, stroke, as well as a chronic obstructive pulmonary disease, were the next leading causes of death.
The US market dominated the North America Wearable Injectors Market by Country 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $3,597.8 Million by 2028. The Canada market estimated to grow at a CAGR of 11.4% during (2022 - 2028). Additionally, The Mexico market would showcase a CAGR of 10.4% during (2022 - 2028).
Based on Therapy, the market is segmented into Diabetes, Cardiovascular disease, Immuno-oncology, and Others. Based on End User, the market is segmented into Hospitals & Clinics and Home healthcare setting. Based on Type, the market is segmented into On-body Injector and Off-body Injector. Based on Technology, the market is segmented into Spring Based, Motor Based, Rotary pump, Expanding battery, and others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Wearable Injectors Market is Estimated to reach $12.9 Billion by 2028, at a CAGR of 9.2%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Insulet Corporation, United Therapeutics Corporation, ATS Automation Tooling Systems, Inc., Ypsomed AG, Amgen, Inc., West Pharmaceutical Services, Inc., Zealand Pharma A/S (Valeritas, Inc.), Medtronic PLC, CeQur SA, and Subcuject ApS.
Scope of the Study
Market Segments Covered in the Report:
By Therapy
- Diabetes
- Cardiovascular disease
- Immuno-oncology
- Others
By End User
- Hospitals & Clinics
- Home healthcare setting
By Type
- On-body Injector
- Off-body Injector
By Technology
- Spring Based
- Motor Based
- Rotary pump
- Expanding battery
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Insulet Corporation
- United Therapeutics Corporation
- ATS Automation Tooling Systems, Inc.
- Ypsomed AG
- Amgen, Inc.
- West Pharmaceutical Services, Inc.
- Zealand Pharma A/S (Valeritas, Inc.)
- Medtronic PLC
- CeQur SA
- Subcuject ApS
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Wearable Injectors Market, by Therapy
1.4.2 North America Wearable Injectors Market, by End User
1.4.3 North America Wearable Injectors Market, by Type
1.4.4 North America Wearable Injectors Market, by Technology
1.4.5 North America Wearable Injectors Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.2.5 Business Expansions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2018,Apr – 2022, Apr) Leading Players
Chapter 4. North America Wearable Injectors Market by Therapy
4.1 North America Diabetes Market by Country
4.2 North America Cardiovascular disease Market by Country
4.3 North America Immuno-oncology Market by Country
4.4 North America Others Market by Country
Chapter 5. North America Wearable Injectors Market by End User
5.1 North America Hospitals & Clinics Market by Country
5.2 North America Home healthcare setting Market by Country
Chapter 6. North America Wearable Injectors Market by Type
6.1 North America On-body Injector Market by Country
6.2 North America Off-body Injector Market by Country
Chapter 7. North America Wearable Injectors Market by Technology
7.1 North America Spring Based Market by Country
7.2 North America Motor Based Market by Country
7.3 North America Rotary pump Market by Country
7.4 North America Expanding battery Market by Country
7.5 North America Others Market by Country
Chapter 8. North America Wearable Injectors Market by Country
8.1 US Wearable Injectors Market
8.1.1 US Wearable Injectors Market by Therapy
8.1.2 US Wearable Injectors Market by End User
8.1.3 US Wearable Injectors Market by Type
8.1.4 US Wearable Injectors Market by Technology
8.2 Canada Wearable Injectors Market
8.2.1 Canada Wearable Injectors Market by Therapy
8.2.2 Canada Wearable Injectors Market by End User
8.2.3 Canada Wearable Injectors Market by Type
8.2.4 Canada Wearable Injectors Market by Technology
8.3 Mexico Wearable Injectors Market
8.3.1 Mexico Wearable Injectors Market by Therapy
8.3.2 Mexico Wearable Injectors Market by End User
8.3.3 Mexico Wearable Injectors Market by Type
8.3.4 Mexico Wearable Injectors Market by Technology
8.4 Rest of North America Wearable Injectors Market
8.4.1 Rest of North America Wearable Injectors Market by Therapy
8.4.2 Rest of North America Wearable Injectors Market by End User
8.4.3 Rest of North America Wearable Injectors Market by Type
8.4.4 Rest of North America Wearable Injectors Market by Technology
Chapter 9. Company Profiles
9.1 Insulet Corporation
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Regional Analysis
9.1.4 Research & Development Expenses
9.1.5 Recent strategies and developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.1.5.2 Approvals anf Trials:
9.2 United Therapeutics Corporation
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Regional Analysis
9.2.4 Research & Development Expenses
9.2.5 Recent strategies and developments:
9.2.5.1 Product Launches and Product Expansions:
9.2.5.2 Acquisition and Mergers:
9.3 ATS Automation Tooling Systems, Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Regional Analysis
9.4 Ypsomed AG
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Recent Strategies and Developments:
9.4.4.1 Partnerships, Collaborations, and Agreements:
9.4.4.2 Business Expansions:
9.5 Amgen, Inc.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Regional Analysis
9.5.5 Recent Strategies and Developments:
9.5.5.1 Acquisitions and Mergers:
9.6 West Pharmaceutical Services, Inc.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expense
9.6.5 Recent Strategies and Developments:
9.6.5.1 Partnerships, Collaborations and Agreements:
9.6.5.2 Product Launches and Product Expansions:
9.7 Zealand Pharma A/S (Valeritas, Inc.)
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Research & Development Expenses
9.7.4 Recent strategies and developments:
9.7.4.1 Partnerships, Collaborations and Agreements:
9.8 Medtronic PLC
9.8.1 Company overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expenses
9.8.5 Recent strategies and developments:
9.8.5.1 Product Launches and Product Expansions:
9.8.5.2 Acquisition and Mergers:
9.9 CeQur SA
9.9.1 Company Overview
9.9.2 Recent strategies and developments:
9.9.2.1 Acquisition and Mergers:
9.10. Subcuject ApS
9.10.1 Company Overview
9.10.2 Recent strategies and developments:
9.10.2.1 Partnerships, Collaborations, and Agreements:
TABLE 1 North America Wearable Injectors Market, 2018 - 2021, USD Million
TABLE 2 North America Wearable Injectors Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Wearable Injectors Market
TABLE 4 Product Launches And Product Expansions– Wearable Injectors Market
TABLE 5 Acquisition and Mergers– Wearable Injectors Market
TABLE 6 Approvals and Trials - Wearable Injectors Market
TABLE 7 Business Expansions- Wearable Injectors Market
TABLE 8 North America Wearable Injectors Market by Therapy, 2018 - 2021, USD Million
TABLE 9 North America Wearable Injectors Market by Therapy, 2022 - 2028, USD Million
TABLE 10 North America Diabetes Market by Country, 2018 - 2021, USD Million
TABLE 11 North America Diabetes Market by Country, 2022 - 2028, USD Million
TABLE 12 North America Cardiovascular disease Market by Country, 2018 - 2021, USD Million
TABLE 13 North America Cardiovascular disease Market by Country, 2022 - 2028, USD Million
TABLE 14 North America Immuno-oncology Market by Country, 2018 - 2021, USD Million
TABLE 15 North America Immuno-oncology Market by Country, 2022 - 2028, USD Million
TABLE 16 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 17 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 18 North America Wearable Injectors Market by End User, 2018 - 2021, USD Million
TABLE 19 North America Wearable Injectors Market by End User, 2022 - 2028, USD Million
TABLE 20 North America Hospitals & Clinics Market by Country, 2018 - 2021, USD Million
TABLE 21 North America Hospitals & Clinics Market by Country, 2022 - 2028, USD Million
TABLE 22 North America Home healthcare setting Market by Country, 2018 - 2021, USD Million
TABLE 23 North America Home healthcare setting Market by Country, 2022 - 2028, USD Million
TABLE 24 North America Wearable Injectors Market by Type, 2018 - 2021, USD Million
TABLE 25 North America Wearable Injectors Market by Type, 2022 - 2028, USD Million
TABLE 26 North America On-body Injector Market by Country, 2018 - 2021, USD Million
TABLE 27 North America On-body Injector Market by Country, 2022 - 2028, USD Million
TABLE 28 North America Off-body Injector Market by Country, 2018 - 2021, USD Million
TABLE 29 North America Off-body Injector Market by Country, 2022 - 2028, USD Million
TABLE 30 North America Wearable Injectors Market by Technology, 2018 - 2021, USD Million
TABLE 31 North America Wearable Injectors Market by Technology, 2022 - 2028, USD Million
TABLE 32 North America Spring Based Market by Country, 2018 - 2021, USD Million
TABLE 33 North America Spring Based Market by Country, 2022 - 2028, USD Million
TABLE 34 North America Motor Based Market by Country, 2018 - 2021, USD Million
TABLE 35 North America Motor Based Market by Country, 2022 - 2028, USD Million
TABLE 36 North America Rotary pump Market by Country, 2018 - 2021, USD Million
TABLE 37 North America Rotary pump Market by Country, 2022 - 2028, USD Million
TABLE 38 North America Expanding battery Market by Country, 2018 - 2021, USD Million
TABLE 39 North America Expanding battery Market by Country, 2022 - 2028, USD Million
TABLE 40 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 41 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 42 North America Wearable Injectors Market by Country, 2018 - 2021, USD Million
TABLE 43 North America Wearable Injectors Market by Country, 2022 - 2028, USD Million
TABLE 44 US Wearable Injectors Market, 2018 - 2021, USD Million
TABLE 45 US Wearable Injectors Market, 2022 - 2028, USD Million
TABLE 46 US Wearable Injectors Market by Therapy, 2018 - 2021, USD Million
TABLE 47 US Wearable Injectors Market by Therapy, 2022 - 2028, USD Million
TABLE 48 US Wearable Injectors Market by End User, 2018 - 2021, USD Million
TABLE 49 US Wearable Injectors Market by End User, 2022 - 2028, USD Million
TABLE 50 US Wearable Injectors Market by Type, 2018 - 2021, USD Million
TABLE 51 US Wearable Injectors Market by Type, 2022 - 2028, USD Million
TABLE 52 US Wearable Injectors Market by Technology, 2018 - 2021, USD Million
TABLE 53 US Wearable Injectors Market by Technology, 2022 - 2028, USD Million
TABLE 54 Canada Wearable Injectors Market, 2018 - 2021, USD Million
TABLE 55 Canada Wearable Injectors Market, 2022 - 2028, USD Million
TABLE 56 Canada Wearable Injectors Market by Therapy, 2018 - 2021, USD Million
TABLE 57 Canada Wearable Injectors Market by Therapy, 2022 - 2028, USD Million
TABLE 58 Canada Wearable Injectors Market by End User, 2018 - 2021, USD Million
TABLE 59 Canada Wearable Injectors Market by End User, 2022 - 2028, USD Million
TABLE 60 Canada Wearable Injectors Market by Type, 2018 - 2021, USD Million
TABLE 61 Canada Wearable Injectors Market by Type, 2022 - 2028, USD Million
TABLE 62 Canada Wearable Injectors Market by Technology, 2018 - 2021, USD Million
TABLE 63 Canada Wearable Injectors Market by Technology, 2022 - 2028, USD Million
TABLE 64 Mexico Wearable Injectors Market, 2018 - 2021, USD Million
TABLE 65 Mexico Wearable Injectors Market, 2022 - 2028, USD Million
TABLE 66 Mexico Wearable Injectors Market by Therapy, 2018 - 2021, USD Million
TABLE 67 Mexico Wearable Injectors Market by Therapy, 2022 - 2028, USD Million
TABLE 68 Mexico Wearable Injectors Market by End User, 2018 - 2021, USD Million
TABLE 69 Mexico Wearable Injectors Market by End User, 2022 - 2028, USD Million
TABLE 70 Mexico Wearable Injectors Market by Type, 2018 - 2021, USD Million
TABLE 71 Mexico Wearable Injectors Market by Type, 2022 - 2028, USD Million
TABLE 72 Mexico Wearable Injectors Market by Technology, 2018 - 2021, USD Million
TABLE 73 Mexico Wearable Injectors Market by Technology, 2022 - 2028, USD Million
TABLE 74 Rest of North America Wearable Injectors Market, 2018 - 2021, USD Million
TABLE 75 Rest of North America Wearable Injectors Market, 2022 - 2028, USD Million
TABLE 76 Rest of North America Wearable Injectors Market by Therapy, 2018 - 2021, USD Million
TABLE 77 Rest of North America Wearable Injectors Market by Therapy, 2022 - 2028, USD Million
TABLE 78 Rest of North America Wearable Injectors Market by End User, 2018 - 2021, USD Million
TABLE 79 Rest of North America Wearable Injectors Market by End User, 2022 - 2028, USD Million
TABLE 80 Rest of North America Wearable Injectors Market by Type, 2018 - 2021, USD Million
TABLE 81 Rest of North America Wearable Injectors Market by Type, 2022 - 2028, USD Million
TABLE 82 Rest of North America Wearable Injectors Market by Technology, 2018 - 2021, USD Million
TABLE 83 Rest of North America Wearable Injectors Market by Technology, 2022 - 2028, USD Million
TABLE 84 Key Information – Insulet corporation
TABLE 85 Key Information – United Therapeutics Corporation
TABLE 86 Key Information – ATS Automation Tooling Systems, Inc.
TABLE 87 Key Information – Ypsomed AG
TABLE 88 Key Information – Amgen, Inc.
TABLE 89 Key information – West Pharmaceutical Services, Inc.
TABLE 90 Key Information – Zealand Pharma A/S
TABLE 91 Key Information – Medtronic PLC
TABLE 92 Key Information – CeQur SA
TABLE 93 Key Information – Subcuject ApS
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2018,Apr – 2022, Apr) Leading Players
FIG 5 Recent strategies and developments: United Therapeutics Corporation
FIG 6 Recent strategies and developments: Ypsomed AG
FIG 7 Recent Strategies and Developments: West Pharmaceutical Services, Inc.
FIG 8 Recent strategies and developments: Medtronic PLC